# Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A Closer Look at Its Valuation and Growth Potential

- Link: https://www.directorstalkinterviews.com/acadia-healthcare-company-inc-achc-stock-analysis-a-closer-look-at-its-valuation-and-growth-potential/4121244982
- Published: 2026-03-17T11:11:56+00:00
- Author: Madison Wilson

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands as a prominent player in the
U.S. healthcare sector, specializing in providing a range of behavioral healthcare
services. With a market capitalization of $2.1 billion, Acadia’s footprint spans
across the United States and Puerto Rico, offering acute inpatient psychiatric care,
residential treatment for eating disorders, and various outpatient services. Founded
in 2005 and headquartered in Franklin, Tennessee, Acadia has made significant strides
within the medical care facilities industry.

Investors with an eye on Acadia Healthcare may note the company’s current stock 
price of $22.79, which marks a slight decrease of 0.03% from the previous trading
session. Over the past 52 weeks, the stock has oscillated between $11.68 and $30.32,
indicating a broad range of volatility and potential for investors willing to navigate
the behavioral healthcare market.

From a valuation standpoint, Acadia’s forward P/E ratio is positioned at 13.60, 
suggesting a potentially favorable outlook for future earnings. However, other valuation
metrics such as the PEG ratio and price-to-book value are unavailable, which might
pose challenges for investors seeking a comprehensive valuation framework. The absence
of a trailing P/E ratio further underscores the complexities in assessing Acadia’s
current earnings performance.

Performance metrics reveal a mixed picture. The company’s revenue growth stands 
at a respectable 6.10%, showcasing its expansion capabilities. However, the net 
income and earnings per share (EPS) are not available, and the return on equity 
is notably negative at -40.96%. Furthermore, the free cash flow is deep in the red
at -$370 million, indicating potential liquidity challenges and a need for strategic
financial management.

For income-focused investors, Acadia does not offer a dividend yield, with a payout
ratio of 0.00%. This suggests that the company is reinvesting earnings back into
operations or expansion opportunities rather than distributing them to shareholders.

Analyst sentiment towards Acadia Healthcare presents a cautiously optimistic outlook.
Among the analyst ratings, there are seven buy ratings, six hold ratings, and one
sell rating. The target price range of $13.00 to $30.00 suggests varied expectations,
with the average target price slightly below the current trading price at $22.71,
indicating a potential downside of -0.33%.

Technical indicators provide additional insights into Acadia’s market performance.
The stock’s 50-day moving average of $17.14 and 200-day moving average of $19.85
highlight the recent upward momentum in its trading price, albeit with an RSI of
32.30, which is approaching oversold territory. The MACD and signal line figures
suggest a potential bullish crossover, which technical traders might interpret as
a positive sign for future price movements.

As Acadia Healthcare continues to navigate the complexities of the behavioral healthcare
industry, investors will need to weigh the potential for growth against the financial
and operational challenges outlined in its performance metrics. The company’s strategic
reinvestment decisions and capacity to drive revenue growth will be crucial in determining
its long-term success and shareholder value.

Share on: